TheraFlu LAR spray 30ml

TheraFlu LAR spray instruction for use

To buy TheraFlu LAR spray just add it to your shopping cart

Structure

1 ml contains:
Active ingredients: benzoxonium chloride 2 mg, lidocaine hydrochloride 1.5 mg;
Excipients: ethanol, peppermint oil, menthol, glycerol, hydrochloric acid, purified water.

pharmachologic effect

TheraFlu LAR spray has an antiseptic, anti-inflammatory effect.

Pharmacodynamics

Benzoxonium chloride - Quaternary ammonium salt: N-benzyl-N-dodecyl N, N-di (2-hydroxyethyl) ammonium chloride. Due to the cationic structure, it has membrane-active activity and has a pronounced antibacterial effect on gram-positive and, to a lesser extent, gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses).
Lidocaine is a local anesthetic that, with inflammatory processes, reduces pain in the throat when swallowing.

Pharmacokinetics

Benzoxonium chloride is practically not absorbed. About 1% of the applied dose is found in urine, the concentration of a substance in the blood is practically not detected. No accumulation of substance in the tissues of the body was detected.
Lidocaine is absorbed by oral administration and through the mucous membrane of the oral cavity. Metabolized upon first passage through the liver, with oral administration, bioavailability is approximately 35%. Metabolites are excreted together with urine; less than 10% of the substance is excreted unchanged.

Indications

Infectious and inflammatory diseases of the oral cavity and pharynx:
    stomatitis;
    pharyngitis;
    ulcerative gingivitis;
    catarrhal tonsillitis;
    laryngitis;
    chronic tonsillitis (as an adjuvant).

Pregnancy and lactation

TheraFlu LAR spray is contraindicated for use in the first trimester of pregnancy and during lactation (breastfeeding).
Adequate and strictly controlled clinical studies of the safety of TheraFlu LAR spray during pregnancy have not been conducted. The use of the drug in the II and III trimesters is not recommended.
There is no clinical data on the allocation of active substances with breast milk. However, the drug is not recommended for use during breastfeeding.
In experimental studies, no effect of TheraFlu LAR spray on reproductive function and fetal development was found.
Contraindicated: children under 4 years old.

Contraindications

Hypersensitivity to lidocaine or ammonia compounds

Side effects

Perhaps the development of local irritation; when used for more than 2 weeks, a reversible brown coloration of the tongue and teeth.

How to take, course of administration and dosage

TheraFlu LAR spray is applied topically.
Solution in the form of a spray: spray in the oral cavity, holding the spray can vertically.
Adults - 4 sprays (approximately 0.5 ml) 3–6 times a day.
Children aged 4 years and older - 1 to 2–3 sprays 3–6 times a day.
The duration of treatment is no more than 5 days. If symptom relief is not observed within 5 days of therapy, the patient should consult a doctor.

Special instructions

During the use of spray TheraFlu LAR, alcohol should be avoided.

Terms of sell

You don't need a prescription from a doctor to buy TheraFlu LAR spray.